These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28475688)

  • 1. Oxaliplatin inhibits proliferation and migration of human hepatocellular carcinoma cells via GAS7C and the N-WASP/FAK/F-actin pathway.
    Li D; Zhang B; Hu C
    Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):581-587. PubMed ID: 28475688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer.
    Tseng RC; Chang JW; Mao JS; Tsai CD; Wu PC; Lin CJ; Lu YL; Liao SY; Cheng HC; Hsu HS; Wang YC
    Oncotarget; 2015 Dec; 6(42):44207-21. PubMed ID: 26506240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H
    Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akebia trifoliata (Thunb.) Koidz Seed Extract inhibits human hepatocellular carcinoma cell migration and invasion in vitro.
    Lu WL; Yang T; Song QJ; Fang ZQ; Pan ZQ; Liang C; Jia DW; Peng PK
    J Ethnopharmacol; 2019 Apr; 234():204-215. PubMed ID: 30528882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
    Lim SC; Choi JE; Kang HS; Han SI
    Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth.
    Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Sun J; Tan CJ; Dai Z
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1595-604. PubMed ID: 19780708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway.
    Sun J; Luo Q; Liu L; Yang X; Zhu S; Song G
    Toxicology; 2017 Jun; 384():1-10. PubMed ID: 28395993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma.
    Ding S; Chen G; Zhang W; Xing C; Xu X; Xie H; Lu A; Chen K; Guo H; Ren Z; Zheng S; Zhou L
    J Transl Med; 2015 Jul; 13():237. PubMed ID: 26198300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.
    Xiong W; Ren ZG; Qiu SJ; Sun HC; Wang L; Liu BB; Li QS; Zhang W; Zhu XD; Liu L; Wang WQ; Tang ZY
    BMC Cancer; 2010 May; 10():219. PubMed ID: 20487542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway.
    Ku CY; Wang YR; Lin HY; Lu SC; Lin JY
    PLoS One; 2015; 10(5):e0126725. PubMed ID: 25978354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling.
    Grbčić P; Tomljanović I; Klobučar M; Kraljević Pavelić S; Lučin K; Sedić M
    Biochem Biophys Res Commun; 2017 Jun; 487(4):782-788. PubMed ID: 28433634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of focal adhesion kinase on the motility, proliferation and apoptosis of Caco2 and SMMC-7721 cells.
    Gao N; He H; Xiao L; Gao X; Shi H; Wu Q; Xu N; Lei Y; Song X; Hou Y
    Med Oncol; 2015 Apr; 32(4):125. PubMed ID: 25790781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells.
    Kim YW; Jang EJ; Kim CH; Lee JH
    Chem Biol Interact; 2017 Jan; 261():108-117. PubMed ID: 27871897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
    Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
    Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
    Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.
    Kuang Y; El-Khoueiry A; Taverna P; Ljungman M; Neamati N
    Mol Oncol; 2015 Nov; 9(9):1799-814. PubMed ID: 26160429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.